Clinical research and drug development in Latin America: Weighing the pros and cons, talking about the future

Journal of Investigative Medicine

Volumn 55, Issue 5, 2007, Pages 223-229

  Rodrigues, D G ^a,b  

^a Libbs Pharmaceuticals Ltd   (Brazil)

^b NONE   (Brazil)

Author keywords

Clinical trial; Drug; Latin America; Research and development

Indexed keywords

CLINICAL PRACTICE; CLINICAL RESEARCH; DEVELOPED COUNTRY; DRUG COST; DRUG INDUSTRY; DRUG RESEARCH; LAW; REVIEW;

EID: 35048821966     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.2310/6650.2007.00007     Document Type: Review

References (17)

1. Kenneth AG. A growing trend in the industry has many pharmaceutical companies looking to manage the changing mix of global clinical trial locations. Appl Clin Trials 2005;14(12):21-2.
2. CenterWatch Drugs in Clinical Trials Database. Available at: http://www.centerwatch.com/professional/cwpipeline/ (accessed Jan 21, 2007).
3. Price Waterhouse Coopers. Latin America prescription for growth, 2005. Available at: http://www.pwc.com/ext.web/onlinefirms.net (accessed Dec 12, 2006).
4. GlaxoSmithKline corporate responsibility report, 2005. Available at: http://www.gsk.com (accessed Dec 11, 2006).
5. Center Watch surveys of Europe (2004), USA (2005) and Latin America (2005). Available at: http://www.center-watch.com/professional/inddir/inddir. html (accessed Nov 4, 2006).
6. Reveiz L, Delgado MB, Urrutia G, et al. The Latin America Ongoing Clinical Trial Register (LATINREC). Pan Am J Public Health 2006;19:417-22.
7. Thomson CenterWatch Survey, Boston, 2005. Available at: http://search.centerwatch.com. (accessed Oct 24, 2006).
8. Thomson ISI, SCI and SSCI National Science Foundation, Division of Science Resource Statists, special tabulations. Available at: http://www.isisnet.com/products/citation/;ipIQ,Inc (accessed Nov 26, 2006).
9. Levine RJ. The impact of HIV infection on society's perception of clinical trials. Kennedy Inst Ethics J 1994;4:93-8.
10. Palca J. African AIDS: whose research rules? Science 1990;250:199-201.
11. Verastegui EL. Consenting of the vulnerable: the informed consent procedure in advanced cancer patients in Mexico. BMC Med Ethics 2006;13(7)E13.
12. Glancspigel D. Clinical trials in Latin America - meeting the challenges can reduce time-to-market. Appl Clin Trials 2003;12:38-41.
13. Clinical Trials in Latin America. Available at: http://www.fast-track. com/pdfs/ClinicalTrialsLatinAmerica.pdf (accessed Dec 11, 2006).
14. Ryan MR, Brazil's quiet bio-medical innovation revolution: drugs, patents, and the "10/90 Health Research Gap" Creative and Innovative Economy Center report. The George Washington University Law School: Washington, DC. 2006, p. 30.
15. Marques F. Fundamental Stone, Revista Pesquisa Fapesp, September, 2006. Available: http://www.revistapesqui.sa.fapesp.br (acessed Nov 23, 2006).
16. New Science geography, Revista Pesquisa Fapesp, March, 2007. Available: http://www.revistapesquisa.fapesp.br (acessed Mar 28, 2006).
17. Chaves GC, Oliveira MA. A proposal for measuring the degree of public health-sensitivity of patent legislation in the context of the WTO TRIPS Agreement. Bull World Health Organ 2007;85(1):49-56.